ArticleThoracic cancer2022

Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification.

Xiaoyi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.